Research + Development - Verséa

SCIENCEResearch & Development

Research & Development are the foundation of Verséa Holdings, Inc.

Verséa Pharmaceuticals Division is engaged in drug discovery, research, development and licensing of innovative medicines in areas of high needs. The goal of our R&D is to build a robust pipeline of highly qualified and characterized new chemical entities and botanical entities for advancement down a clinical pathway with the FDA.

Verséa Biologics is using the latest cutting-edge scientific advancements in regenerative medicine to provide novel treatment solutions for a broad range of musculoskeletal and regenerative conditions that support the body’s natural ability to heal.

Verséa Discovery utilizes proprietary VCX™ Discovery Platform to assess therapeutic potentials & risks of new drug candidates in a fast, cost-efficient way.

Verséa Diagnostics is focused on staying up to date with new diagnostic discoveries. Thanks to our long-lasting partnerships with world’s manufacturing leaders and R&D alliances with Clinical Research Organizations (CROs) we are able to provide POC and OTC diagnostic solutions (EUA, FDA approved) of highest quality and precision.

Verséa Wellness uses patented technology to deliver highly efficient, clinical-grade formulations that provide 4.4x better absorption.

IRB Patient Registry

Verséa is the first company in the United States to fund and initiate an IRB approved patient registry tracking the real-world utilization of Verséa products. In advance of pipeline assets entering clinical development, the data generated from the registry will be first of its kind and will be published in the medical literature and utilized to support development packages submitted to FDA. To date over 300 patients have been enrolled into the registry.


R & D Cooperation

If you are interested in cooperating with us, let us know!